Carl Lebel
Chief Operating Officer, AKESIS PHARMACEUTICALS, INC.
Companies
- Korro Bio, Inc.Chief Development Officer Oct 2, 2019 to Jan 27, 20231
- Otonomy (United States)Chief Scientific Officer Aug 12, 2014 to Nov 22, 20162
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Korro Bio, Inc. KRRO26,343 shares3$227.1K at $8.62Jul 6, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 6, 2022Sold 4,421 shares at $1.52 of Korro Bio, Inc.3
- Jul 5, 2022Exercised options 15,000 shares of Korro Bio, Inc.3
- Feb 22, 2022Sold 1,069 shares at $3.53 of Korro Bio, Inc.4
- Feb 18, 2022Sold 974 shares at $3.87 of Korro Bio, Inc.4
- Feb 17, 2022Sold 901 shares at $4.19 of Korro Bio, Inc.5
- Feb 16, 2022Sold 831 shares at $4.43 of Korro Bio, Inc.5
- Feb 15, 2022Sold 844 shares at $4.33 of Korro Bio, Inc.6
- Feb 14, 2022Exercised options 15,000 shares of Korro Bio, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Feb 23, 2022
- 5SEC EDGARForm 4 filed Feb 18, 2022
- 6SEC EDGARForm 4 filed Feb 16, 2022